InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.090 0.009 (11.11%)+

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$32 Genetype Publication Market Update 11 Jun 2025 9:08AM $0.060 $0.090 risen by 50%
$32 Change in substantial holding - Michelle Wing 10 Jun 2025 5:26PM $0.060 $0.090 risen by 50%
$32 Cleansing Notice 2 Jun 2025 3:20PM $0.062 $0.090 risen by 45.16%
$32 Application for quotation of securities - RHY 2 Jun 2025 3:06PM $0.062 $0.090 risen by 45.16%
$32 Investor Presentation 2 Jun 2025 9:07AM $0.065 $0.090 risen by 38.46%
$32 Proposed issue of securities - RHY 30 May 2025 10:08AM $0.065 $0.090 risen by 38.46%
$32 ColoSTAT Beta kit verification and validation update 26 May 2025 8:53AM $0.061 $0.090 risen by 47.54%
$32 Breast Cancer Risk Study University of Melbourne 15 May 2025 9:02AM $0.064 $0.090 risen by 40.63%
$32 Notification regarding unquoted securities - RHY 2 May 2025 12:45PM $0.062 $0.090 risen by 45.16%
$32 Proposed issue of securities - RHY 1 May 2025 4:21PM $0.056 $0.090 risen by 60.71%
$32 Quarterly Activities Report and Appendix 4C 31 March 2025 24 Apr 2025 9:17AM $0.075 $0.090 risen by 20%
$32 RHY ISO13485 Recert Market Update 14 Apr 2025 9:34AM $0.078 $0.090 risen by 15.38%
$32 Application for quotation of securities - RHY 11 Apr 2025 9:40AM $0.075 $0.090 risen by 20%
$32 Change in substantial holding 8 Apr 2025 10:46AM $0.070 $0.090 risen by 28.57%
$32 RHY - Results of Meeting 31 Mar 2025 12:15PM $0.080 $0.090 risen by 12.50%
$32 EGM - Investor Presentation 31 Mar 2025 8:23AM $0.080 $0.090 risen by 12.50%
$32 RHY Genetype Commercial Sales 19 Mar 2025 9:06AM $0.089 $0.090 risen by 1.12%
$32 Notification regarding unquoted securities - RHY 18 Mar 2025 2:16PM $0.091 $0.090 fallen by 1.10%
$32 Appointment of Chief Financial Officer 18 Mar 2025 9:06AM $0.085 $0.090 risen by 5.88%
$32 Notification of cessation of securities - RHY 17 Mar 2025 5:00PM $0.085 $0.090 risen by 5.88%
$32 RHY Investor Webinar 5 Mar 2025 9:40AM $0.093 $0.090 fallen by 3.23%
$32 RHY - EGM Notice of Meeting and Proxy Form 27 Feb 2025 9:20AM $0.094 $0.090 fallen by 4.26%
$32 Investor Webinar 27 Feb 2025 9:01AM $0.094 $0.090 fallen by 4.26%
$32 Half-Year Financial Report and Appendix 4D 21 Feb 2025 8:39AM $0.093 $0.090 fallen by 3.23%
$32 Becoming a substantial holder 12 Feb 2025 5:13PM $0.090 $0.090 fallen by 0%

126 - 150 of 639 results

Page 6 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.